FDA Drug Application (021611) for OPANA by ENDO PHARMS

Back to FDA Applications sponsored by ENDO PHARMS

Application Number021611
Product Number001
FormTABLET;ORAL
Dosage5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameOPANA
Active IngredientOXYMORPHONE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient OXYMORPHONE HYDROCHLORIDE4


Back to FDA Applications sponsored by ENDO PHARMS